You are here

Abrysvo

GSK outpaces Pfizer in RSV vaccine market

GSK outpaces Pfizer in RSV vaccine market

BioPharma Dive

Flag link:

Pfizer RSV vaccine gets off to fast start on market

Pfizer RSV vaccine gets off to fast start on market

BioPharma Dive

Flag link:

Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US

Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US

Clinical Trials Arena

Flag link:

FDA approves Pfizer’s RSV vaccine for use in pregnancy

FDA approves Pfizer’s RSV vaccine for use in pregnancy

BioPharma Dive

Flag link:

FDA approves Pfizer’s RSV vaccine for older adults

FDA approves Pfizer’s RSV vaccine for older adults

Stat

Flag link:

FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel

FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel

BioSpace

Flag link:

Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions

Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions

Fierce Biotech

Flag link: